ID: ALA559435

Max Phase: Preclinical

Molecular Formula: C26H24F3N5O3S

Molecular Weight: 543.57

Molecule Type: Small molecule

Representations

Canonical SMILES:  NS(=O)(=O)c1ccc(Nc2nc3cc(C(=O)N4CCCC4)ccc3n2Cc2ccccc2C(F)(F)F)cc1

Standard InChI:  InChI=1S/C26H24F3N5O3S/c27-26(28,29)21-6-2-1-5-18(21)16-34-23-12-7-17(24(35)33-13-3-4-14-33)15-22(23)32-25(34)31-19-8-10-20(11-9-19)38(30,36)37/h1-2,5-12,15H,3-4,13-14,16H2,(H,31,32)(H2,30,36,37)

Standard InChI Key:  AOVQBOCWSBTAIM-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 543.57

Molecular Weight (Monoisotopic): 543.1552

AlogP: 4.73

#Rotatable Bonds: 6

Polar Surface Area: 110.32

Molecular Species: NEUTRAL

HBA: 6

HBD: 2

#RO5 Violations: 1

HBA (Lipinski): 8

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 10.72

CX Basic pKa: 5.55

CX LogP: 4.52

CX LogD: 4.51

Aromatic Rings: 4

Heavy Atoms: 38

QED Weighted: 0.37

Np Likeness Score: -1.89

References

1. Lahue BR, Ma Y, Shipps GW, Seghezzi W, Herbst R..  (2009)  Substituted benzimidazoles: A novel chemotype for small molecule hKSP inhibitors.,  19  (13): [PMID:19481450] [10.1016/j.bmcl.2009.05.040]

Source

Source(1):

• Scientific Literature